Table 1.

Basic clinical characteristics of the 15 lung cancer patients

Patient ID	Age (year)	Gender	Pathological type	Differentiation	TNM stage
P1	62	Male	ADC	L	T3N2M0 (III)
P2	56	Female	ADC	L	T2bN0M0 (I)
P3	57	Male	ADC	L	T2aN0M0 (I)
P4	43	Female	ADC	H	T1N0M0 (I)
P5	73	Male	SCC	L	T2aN2M0 (III)
P6	65	Male	SCLC	–	T2aN0M0 (I)
P7	76	Male	SCC	M	T1aN1M0 (II)
P8	73	Male	ADC	L	T2aN2M0 (III)
P9	64	Male	ADC	L	T2bN0M0 (II)
P10	56	Female	ADC	M	T2aN0M0 (I)
P11	64	Male	ADC	M	T1N0M0 (I)
P12	31	Male	ADC	L	T3N2M0 (III)
P13	61	Female	ADC	M	T2N0M0 (I)
P14	73	Female	ADC	H	T1aN0M0 (I)
P15	41	Male	ADC	L	T2N2M0 (III)

Note: ADC, adenocarcinoma; SCC, squamous cell carcinoma; SCLC, small cell lung cancer; L, poorly differentiated; M, moderately differentiated; H, well differentiated.